APA (7th ed.) Citation

N, T., R, M., A, A., D, J., S, S., D, O., . . . L, M. (2021). Role of A Novel Angiogenesis FKBPL-CD44 Pathway in Preeclampsia Risk Stratification and Mesenchymal Stem Cell Treatment. The Journal of clinical endocrinology and metabolism, 106(1), 26. https://doi.org/10.1210/clinem/dgaa403

Chicago Style (17th ed.) Citation

N, Todd, et al. "Role of A Novel Angiogenesis FKBPL-CD44 Pathway in Preeclampsia Risk Stratification and Mesenchymal Stem Cell Treatment." The Journal of Clinical Endocrinology and Metabolism 106, no. 1 (2021): 26. https://doi.org/10.1210/clinem/dgaa403.

MLA (9th ed.) Citation

N, Todd, et al. "Role of A Novel Angiogenesis FKBPL-CD44 Pathway in Preeclampsia Risk Stratification and Mesenchymal Stem Cell Treatment." The Journal of Clinical Endocrinology and Metabolism, vol. 106, no. 1, 2021, p. 26, https://doi.org/10.1210/clinem/dgaa403.